Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes
- 20 July 2026
- journal article
- Published by BMJ in British Journal of Ophthalmology
Abstract
Background and aims: The current study aims to investigate how age, period and cohort effects have shaped the patterns of diabetic retinopathy-related vision loss globally, distinguishing between loss associated with type 1 versus 2 diabetes. Methods: A secondary analysis of data from the Global Burden of Disease (GBD) 2021 study was conducted by using estimates of blindness and vision loss due to DR across different socio-demographic index (SDI) categories. Age-standardised prevalence rates, relative percentage changes, net drift and local drift were analysed. Findings: Globally, age-standardised prevalence (ASPR) of diabetes-related blindness and vision loss rose from 48.8 per 100 000 in 1990 to 67.3 per 100 000 in 2021, with type 1 diabetes-related blindness and vision loss ASPR showing a modest decrease (from 1.8 to 1.7 per 100 000). The highest relative increase was recorded in the high SDI group (45.8%). For Type 1 diabetes, low-middle and low SDI groups exhibited more pronounced declines in associated ASPR. Increasing ASPR with advancing age was consistent across SDI groups though less pronounced for type 1 than type 2 diabetes. Unfavourable period and cohort effects were observed for type 2 but not type 1-related blindness and vision loss risk. High-middle SDI and middle SDI groups showed the most notable increase in period and cohort effect, whereas low-middle and low SDI groups experienced favourable period and cohort risks during the study duration. Conclusions: Substantially different trends were observed for ASPR, period and cohort effects in recent decades for type 1 versus type 2 diabetes across different SDI.Keywords
Funding Information
- Special Project of Science and Technology Innovation Strategy of Guangdong Province (STKJ2023001)
- National Natural Science Foundation of China (82471075)
- the Key Research Platforms and Projects of Guangdong Provincial Universities (2022LSYS006)
- the Key Research Platforms and Projects of Guangdong Provincial Universities (2023KCXTD013)
This publication has 32 references indexed in Scilit:
- GLP-1 Receptor Agonists and Sight-Threatening Ophthalmic Complications in Patients With Type 2 DiabetesJAMA Network Open, 2025
- Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2024
- Trends in prevalence rates of blindness among patients with diabetic retinopathy in high-income countries from 1990 to 2019: A joinpoint regression analysisDiabetes Research and Clinical Practice, 2023
- Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021The Lancet, 2023
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045Ophthalmology, 2021
- Bounding Analyses of Age-Period-Cohort EffectsDemography, 2019
- The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease MechanismsCurrent Diabetes Reports, 2018
- Type 1 diabetesThe Lancet, 2018
- Diabetic retinopathyThe Lancet, 2010